News and Trends 20 Dec 2022
F2G looks for FDA new drug application approval for invasive fungal infections treatment
F2G Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its new drug application (NDA) for olorofim for the treatment of invasive fungal infections…